-2.jpg)
Advancing Multiple Myeloma Research Together
Through Clinical research, the TRIlogy program is helping advance our understanding of
multiple myeloma while exploring potential new treatment options for eligible participants.
Advancing Multiple Myeloma Research Together
Through Clinical research, the TRIlogy program is helping advance our understanding of
multiple myeloma while exploring potential new treatment options for eligible participants.
The TRIlogy program is a collection of clinical studies evaluating an investigational medication for the treatment of multiple myeloma. If you are living with multiple myeloma, you may be eligible to participate in one of our clinical studies. Every path is different, and we are here to help you explore what options may be right for you.
Clinical studies explore investigational medicines.
Around the world, people are coming together to help advance multiple myeloma research.
Multiple myeloma is a type of cancer that starts in the bone marrow, where blood cells are made. It happens when certain cells called plasma cells grow out of control. These cells can hurt your bones, kidneys, and blood.
Research Studies in This Program
Below are the current studies being conducted in our research program focusing on investigational medicines for people with multiple myeloma.
TRIlogy-5
Clinical research studies test the safety and efficacy of an investigational medication in a group of people. This is the only way to find new or better treatment options.
By taking part in a clinical research study you may:
- Get actively involved in your own healthcare
- Help others by advancing medical research